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ABSTRACT Cholinesterases (acetyicholinesterase and
butyryicholinesterase) exhibit additional catalytic activi-
ties apart from their well-known action in hydrolyzing
choline esters. An amine-sensitive aryl acylamidase ac-
tivity is exhibited by both acetyl- and butyrylcholinester-
ases. A metallocarboxypeptidase-like activity is found as-
sociated with both acetyl- and butyrylcholinesterases.
The peptidase activity exhibited by butyrylcholinester-
ase was located in a 50-kDa COOH-terminal fragment.
Acetyicholinesterase is implicated in noncholinergic
functions in the substantia nigra. A relationship between
tumorigenesis, cell differentiation, and cholinesterases
has been speculated. The sequence similarities between
different esterases, lipases, thyroglobulin, cell adhesion
proteins, and cholinesterases would make it appear that
cholinesterases are capable of exhibiting more than one
biological activity and their functions are wider than
what is hitherto known.-Balasubramanian, A. S.,
Bhanumathy, C. D. Noncholinergic functions of
cholinesterases. FASEBJ. 7: 1354-1358; 1993.
Ky Words: acetylcholinesterase butyryicholinesterose. aiyl acylami-
dase . rnetallocarboxypeptidase neural cell differentiation
ACETYLCHOLINESTERASE (ACHE) IS WELL KNOWN for its role
in terminating the action of acetyl choline at the cholinergic
synapses. However, observations made by different investiga-
tors suggested that it may have additional noncholinergic
functions (1, 2). AChE occurs in areas of the brain and in
erythrocyte membrane where no cholinergic functions are
known to take place. Moreover, the enzyme exists in poly-
morphic forms. This diversity in distribution, form, and cel-
lular localization gave the initial impetus to study the possi-
ble additional functions of AChE.
Butyrylcholinesterase (BChE), which is closely related to
AChE, occurs abundantly in human serum and in lesser
amounts in various tissues (3). Cloning and sequencing have
revealed striking sequence homology between the two en-
zymes (4, 5). BChE has 53% amino acid sequence identity
to AChE, shows similar response to a number of classical in-
hibitors of AChE, and differs from AChE in its substrate
preference. No well-established function of BChE is known.
The amino acid sequence at the active site of both AChE
and BChE is well conserved. Besides, an active site serine
residue, a histidine, and a glutamate residue are considered
important for the catalytic activity of both AChE and BChE
(6, 7). The near identity of the two types of cholinesterases
is also reflected in several other properties exhibited by both
of them as described below. The proposed biological activi-
ties of AChE and BChE are given in Table 1.
AN AMINE-SENSITIVE ARYL ACYLAMIDASE (AAA)
ACTIVITY IN AChE AND BChE
Both AChE and BChE exhibit an aryl acylamidase activity
capable of hydrolyzing the acyl amide bond in the substrate
o-nitroacetaniide (8-10). This AAA activity is strongly in-
hibited by classical cholinesterase inhibitors. In addition,
AAA found in cholinesterase is susceptible to selective inhi-
bition by 5-hydroxytryptamine (5HT) (8-10). The exhibition
of a 5HT-sensitive AAA activity by AChE and BChE from
several different sources has been demonstrated (9-14).
Chemical modification studies have indicated overlapping
active sites for AAA and AChE or BChE (15, 16). Yet another
exclusive feature of the AAA activity in human serum BChE
is its severalfold stimulation by tyramine (10, 14, 17). The se-
rum BChE of monkey shows significant tyramine activation
of AAA activity; the monkey is the only animal that shows
immunological identity of its BChE to human BChE (17,
18). The sequence identity between Asn-68 to Leu-208 in se-
rum BChE from human and monkey is 100%, and from
other species nearly 91-97% (18). This would indicate that
unique structural features or sequences exclusively present
in the human and monkey sera BChE and absent in the se-
rum BChE of other species are responsible for the tyramine
stimulation of their AAA activity. In Table 2 the general
characteristics of AAA associated with cholinesterases and
AAA unassociated with cholinesterases are given. The hu-
man liver AAA, not associated with AChE or BChE, does
not show any amine sensitivity and is unaffected by classical
cholinesterase inhibitors.
The difference m the susceptibility to tyramine activation
of AAA from AChE and BChE could be attributed to the se-
quence differences found in these two enzymes. A specific
binding site for tyramine absent in AChE may be present in
BChE. Alternately, BChE but not AChE may undergo a
conformational change caused by tyramine binding. In this
connection the recent modeling studies (19) that reveal the
absence in BChE of six conserved aromatic residues that line
the active-site gorge of AChE is noteworthy. A closer look into
the sequence differences between AChE and BChE and the
binding sites of tyramine will shed light on these possibilities.
A POSSIBLE ROLE OF THE AMINE-SENSITIVE AAA
ACTIVITY
What could be the possible significance of the association of
an AAA activity with cholinesterases and the sensitivity to
amines of these enzymes? The acyl-amide bond cleaved by
AAA is similar to those found in pain-relieving drugs such
as paracetamol and phenacetin. If any such synthetic drug
is cleaved by AAA, then 5HT, which inhibits AAA, may help
prolong the life of such drugs in the circulation and improve
their analgesic effects. 5HT is known to have an effect on
pain relief (20). Attempts to demonstrate the deacetylation
of phenacetin by AAA have been unsuccessful (21). However,
1Abbreviations: AChe, acetylcholinesterase; BChe, butyrylcholin-
esterase; 5HT, 5-hydroxytryptamine; AAA, aryl acylamidase.
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TABLE 1. Proposed biological activities of cholinesterases
Biological activity Cholinesterases involved Reference
Amine-sensitive aryl acylamidase activity AChE, BChE (8-14)
Metallocarboxypeptidase-like activity AChE, BChE (23, 24, 28, 29, 31)
Cocaine hydrolysis BChE (57, 58)
Neural cell differentiation AChE, BChE (39-41)
Cell division and tumorigenesis AChE, BChE (46-48)
Functions in substantia nigra (potassium channel opening) AChE (42-43)
Cell-cell interaction AChE, BChE (59)
it is possible to envisage the existence of an unknown en-
dogenous analgesic compound with an acyl-amide bond sus-
ceptible to cleavage by AAA and its modulation by acetyl-
choline and 5HT, suggesting a role for AChE in pain relief.
Migraine has been correlated with excessive tyramine. A
defective tyramine conjugation has been suggested to be the
reason for excessive tyramine (22). However, the exact rela-
tionship between tyramme and migraine is not clear. It may
be speculated that tyramine promotes the degradation of an
endogenous analgesic acyl-amido compound through stimu-
lation of the AAA in circulation resulting in the derange-
ment of a natural pain relief mechanism. A role for human
serum BChE in the control of amine-sensitive pain mechan-
isms through its AAA modulated by both 5HT and tyramine
remains a possibility.
THE PEPTIDASE ACTIVITY IN AChE AND BChE
Unlike the well-founded findings of AAA association with
AChE and BChE, the presence of a peptidase activity in
cholinesterases has been the subject of divergent observa-
tions from different laboratories. A peptidase activity in
AChE that behaved like trypsin and like a carboxypeptidase
(based on the substrates cleaved) was reported by Small et al.
(23). The carboxypeptidase was also stimulated by divalent
metal ions (24). Subsequently it was reported that the pro-
tease activity associated with purified AChE from human
brain, fetal bovine serum, or electric eel could cleave the
membrane-bound form of the amyloid protein precursor of
Alzheimer’s disease (25). Trypsin activity was suggested to be
a contaminant in commercial electric eel AChE (26).
A dipeptidyl peptidase activity initially reported to be
present in purified BChE was later demonstrated to be a
contaminant and separable from BChE (27). Boopathy and
Balasubramanian (28) observed that purified BChE of hu-
man serum exhibited a peptidase activity that could cleave
amino acids from the COOH-terminus of several peptides.
The peptidase and BChE activities were inseparable under
several conditions of ion exchange, affinity, and molecular
seive chromatography and by electrophoresis. Further, both
activities could be immunoprecipitated by monoclonal anti-
bodies (29). As further evidence, Rao and Balasubramanian
(30, 31) demonstrated that BChE could be cleaved by limited
a-chymotrypsin digestion into enzymatically active frag-
ments of 20 kDa and 50 kDa, the former exhibiting both
BChE and AAA activity and the latter exhibiting peptidase
activity alone. Supporting these findings was the observation
that classical inhibitors of BChE that block the active site ser-
inc had no inhibitory effect on the peptidase activity (28, 31).
The amino-terminal sequencing of these fragments showed
that they arise by cleavage of Tyr (146)-Arg (147) and Phe
(290)-Gly (291) bonds in the BChE molecule (30, 31). These
results suggested that all three enzyme activities reside on the
same polypeptide chain of BChE (Fig. 1). Further, they
presented evidence that the peptidase behaves like a metal-
lopeptidase stimulated by Zn2, Co2, and Mn and that
histidine residues were involved in metal ion stimulation
(29). A His-X-X-Glu sequence suggested to be involved in
metal ion binding (32, 33) in the peptidase domain of BChE
supported these findings. A similar metal binding sequence
is also found in AChE (Table 3).
Checler and Vincent and Checler et al. (34, 35) observed
that protease activities that cleave Leu-enkephalin, sub-
stance P, and neurotensm in electric eel AChE and in human
serum BChE preparations could not be immunoprecipitated
by monoclonal antibodies raised against AChE and BChE,
respectively. Apparently these were contaminating pepti-
dases present in their cholinesterase preparations. This was
also corroborated by the fact that the cleavage products from
Leu-enkephalin in their studies was a tetrapeptide and leu-
cine in contrast to observations by Rao and Balasubrama-
TABLE 2. The comparative characteristics of aryl acylamidases (AAA) associated and unassociated with cholinesterases
Property AAA associated with AChE AAA associated with BChE AAA not associated with cholinesterases
Amine Inhibited by 5-hydroxytryptamine Inhibited by 5-hydroxytryptamine Unaffected by 5-hydroxytryptamine
sensitivity and unaffected by tyramine and stimulated by tyramine and tyramine
Sensitivity to Inhibited by butyrylcholine Inhibited by succinyl Unaffected by choline
choline esters and other choline esters choline and other
choline esters
esters
Sensitivity to Inhibited by eserine, Inhibited by eserine, Not inhibited by the
cholinesterase neostygmine, and the neostygmine, and the cholinesterase
inhibitors AChE-specific inhibitor
BW284C51
BChE-specific inhibitor
tetraisopropyl pyro-
phosphorarnide
inhibitors
domain 3
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domain 1 domain 2
Figure 1. The three domains of human serum BChE isolated by
limited a-chymotrypssn digestion. Domain 1 is an inactive frag-
ment, domain 2 is a fragment exhibiting BChE and AAA activities,
and domain 3 exhibits peptidase activity exclusively. Domain 2,
which is devoid of galactose residues, can be separated from domain
3 by Ricinus communis agglutinin 120-Sepharose chromatography
(30, 31).
nian (29), who found that Leu-enkephalin was cleaved to a
tripeptide and two amino acids from the COOH-terminus
under all conditions of assay. Although separation of con-
taminating peptidases from AChE and BChE does not mean
that they have no peptidase activity, the detailed characteris-
tics of the peptidases really associated with AChE and BChE
need to be fully investigated. Purified BChE from the serum
of monkey, the only animal that shows immunological cross-
reactivity with human BChE antibody, also exhibited a
metallocarboxypeptidase activity with characteristics similar
to that of human BChE (C. D. Bhanumathy, R. V. Rao, and
A. S. Balasubramanian, unpublished results).
The crystal structure of AChE that is closely related to
BChE has revealed that wheat serine carboxypeptidase II
shows a striking similarity to the overall structure of AChE
(7). A great deal of similarity in the folds of wheat serine car-
boxypeptidase II and the zinc exopeptidase carboxypepti-
dase A has been pointed out by Liao and Remington (36).
Their studies also suggested that the structural motif Gly-X-
Ser-X-Gly found at the active site of several serine pro-
teinases or esterases is fortuitous and might not have
diverged from a common ancestor (37). Similarities in
primary sequence between digestive and nondigestive car-
boxypeptidases are only 15-20% (38). In spite of these differ-
ences, sequence alignments clearly show that key residues of
His and Glu for coordination of Zn and Arg, Glu, and Tyr
for catalysis are common to all these enzymes (38).
A ROLE FOR CHOLINESTERASES IN
NEURODIFFERENTIATION
Long before any synaptogenesis occurs in the chicken neural
tube, BChE is seen diffusely distributed along the ventricular
layer whereas AChE is localized in cells along the mantle
layer (39). The appearance of both enzymes correlates with
the end of cell proliferation in different tissues and cell types
of embryonic chicken brain and retina. These observations
on the expression of cholinesterases at critical times during
early neurogenesis have suggested the possibility of their in-
volvement in neurogenetic processes. A correlation between
high proliferative rate and BChE expression has been ob-
served in neuroblasts of the early neural tube, neural crest
cells, retinal cells, and others (40). Layer and co-workers (41)
consider BChE a transmitotic marker because high BChE
activities are typical of cells in a transient state shortly before
final mitosis and the beginning of cellular differentiation.
The expression of AChE arid BChE at early stages of em-
bryogenesis before the formation of synapses also suggests a
morphogenetic role for these enzymes at this stage.
NONCHOLINERGIC EFFECTS OF AChE IN THE
SUBSTANTIA NIGRA AND CEREBELLUM
In the substantia nigra of brain, AChE appears to have a
noncholinergic role. There is a disparity in the high levels of
AChE relative to low levels of acetylcholine in this region.
Moreover, behavioral and electrophysiological actions of
AChE appeared to be unassociated with the hydrolysis of
acetylcholine in substantia nigra (42).
Recent studies by Webb and Greenfield (43) have indi-
cated that an ATP-sensitive potassium channel is operative
in substantia nigra and that AChE has a role in opening this
channel. The reversible hyperpolarizing action of AChE via
an opening of potassium channels on a selective population
of nigral neurons could be identified by an ability to generate
bursts of action potentials. The AChE-induced hyperpolari-
zation was seen with a highly purified preparation of AChE.
These physiological effects of AChE were claimed not to
result from any contaminants present in AChE (43). The
effect of AChE was not attributed to its enzymatic action, as
even a boiled preparation of AChE was efficacious. It was
concluded from these studies that the tertiary structure of
AChE was not needed for this noncholinergic action (43).
In another study (44, 45) a novel, modulatory effect of
AChE in cerebellar Purkinje cells in increasing their ability
to respond to excitatory input and fire Na action potentials
over an expanded range of frequency has been observed. Ir-
reversible inhibition of AChE with soman did not prevent
this action (indicating that acetylcholine hydrolysis was not
involved) and BChE had no effect.
Secretory forms of AChE are implicated in these non-
cholinergic functions (45). Barring the presence of any con-
taminants in the AChE preparations that are responsible for
the observed effects, the studies described above provide
direct evidence for the noncholinergic physiological roles of
AChE in the brain.
TABLE 3. Metal binding sequence (HXXE-H) found in some metallo-peptidases and their comparison to cholinesterases
Enzyme Sequenced Residues Reference
Human insulin degrading enzyme HFCEH 109-113 (33)
Drosophila insulin degrading enzyme HFCEH 81-85 (33)
Bovine carboxy-peptidase A HSRE (X)123 H 69-196 (32)
Bovine carboxy-peptidase B HARE (X)123 H 69-196 (32)
Human BChE HGYE (X)107 H 438-548 (5)
Torpedo AChE HGYE (X)107 H 440-550 (4)
X indicates any amino acid. Single-letter code for amino acids is used.
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CHOLINESTERASES IN TUMORIGENESIS
Many tumor cells that display no detectable electrical
response to acetylcholine have been shown to express
cholinesterases and acetylcholine receptors (46). In many
types of human tumors, cholinesterase genes are abnormally
expressed (46). It is hypothesized that a defective cholinergic
signaling may change the activities of cdc 2-like kinases with
the potential to accelerate the rate of cell division and sup-
port tumor growth (47). The potential substrate proteins of
cdc 2-related kinases as well as AChE and BChE contain the
common peptide motif Ser/Thr-Pro-X-Z, where X is a polar
amino acid and Z is a basic amino acid (48).
CONCLUSIONS AND FUTURE STUDIES
Partial sequences from several different proteins occurring in
the polypeptide chain of one single protein increase the pos-
sibility of one protein exhibiting more than one biological ac-
tivity. Sequence conservation analysis relates the cholinester-
ases to a superfamily of polypeptides including enzymes such
as microsomal carboxylesterase, cholesterol esterase, lysophos-
pholipase, Geotrichum lipase, and Drosophila esterase-6 as well
as noncatalytic polypeptides such as the COOH-terminal
domain of thyroglobulin, and the Drosophila cell adhesion
proteins neurotactin and glutactin (49-56). Therefore the
multiple activities of cholinesterases would not be altogether
surprising. However, their true significance can be recog-
nized only when their role within or outside the cell under
in vivo conditions is evaluated. The amine-sensitive AAA
and peptidase activities of AChE and BChE as well as the
claims of Cocaine hydrolytic activity of BChE (57, 58) raise
interesting possibilities as to the physiological functions of
cholinesterases (Table 1). A linkage between cholinesterases
and cell-cell interaction (59), cell division, neural cell
differentiation, and neural development (46) has been
strengthened by recent findings, and the proposed peptidase
activity of cholinesterases may have a role to play in this
process. An acetylcholine-sensitive hydrolysis of substance P
in rabbit retina caused by a metallopeptidase, a proportion-
ality between AChE activity and substance P hydrolysis (60),
and the findings of carboxypeptidase inhibitors and indolea-
mines selectively inhibiting cholinesterases in histopathologi-
cal structures of Alzheimer’s disease (61) all point toward the
relevance of the AAA and peptidase activities exhibited by
cholinesterases. The existence of different forms of
cholinesterases that differ in their catalytic functions and bio-
logical activities is a distinct possibility that remains to be ex-
plored. Future studies that help to fill in the gaps in our
knowledge and understanding of the additional functions of
cholinesterases would darify the true significance of these
findings. [!]
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